U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07425548) titled 'Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.' on Feb. 16.
Brief Summary: Breast cancer, the most common cancer in women, is increasingly managed as a chronic disease thanks to therapeutic advances. However, treatments such as chemotherapy and hormonotherapy often induce premature menopause in younger women, leading to skin aging, atrophy, and distressing symptoms that negatively affect quality of life. These cutaneous effects are frequently overlooked despite their psychological and social impact. Hyaluronic acid injections, already well established in aesthetic and reco...